Cargando…
Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
Noonan and LEOPARD syndromes (NS and LS) belong to a group of related disorders called RASopathies characterized by abnormalities of multiple organs and systems including hypertrophic cardiomyopathy and dysmorphic facial features. There are no approved drugs for these two rare diseases, but it is kn...
Autores principales: | Zhu, Liyuan, Roberts, Ruth, Huang, Ruili, Zhao, Jinghua, Xia, Menghang, Delavan, Brian, Mikailov, Mike, Tong, Weida, Liu, Zhichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333460/ https://www.ncbi.nlm.nih.gov/pubmed/32676024 http://dx.doi.org/10.3389/fphar.2020.00927 |
Ejemplares similares
-
Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma
por: Liu, Zhichao, et al.
Publicado: (2021) -
Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development
por: Liu, Zhichao, et al.
Publicado: (2020) -
Transcriptional Responses Reveal Similarities Between Preclinical Rat Liver Testing Systems
por: Liu, Zhichao, et al.
Publicado: (2018) -
Craniofacial and cutaneous findings in Noonan, Costello and LEOPARD syndromes
por: Pokrowiecki, Rafał, et al.
Publicado: (2018) -
Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways
por: Sakamuru, Srilatha, et al.
Publicado: (2022)